Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V. Ribrag
Ezh2 Gain-Of-Function Mutations Are Not Associated With More Favorable Prognosis in Relapsed/Refractory Follicular Lymphoma (Fl): A Preliminary Analysis on 590 Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Obinutuzumab Plus Dhap Followed by Autologous Stem Cell Transplantation (Asct) Plus Obinutuzumab Maintenance Provides a High MRD Response Rate in Untreated MCL Patients. Results of Lyma-101 Trial, a Lysa Group Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Rituximab Plus Lenalidomide Is as Effective as Immunochemotherapy in the Eradication of Molecular Disease in Untreated Follicular Lymphoma: Relevance Lysa Ancillary Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Phase I/Ii Study of Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Patients Treated by Chemotherapy (Ice) in Second Line Before Autologous Transplantation.
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Pivotal, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Phase 2 Study of Me-401 Investigating Two Dosing Schedules in Patients With Follicular Lymphoma (Fl) After Failure of Two or More Prior Systemic Therapies
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Feasibility and Benefit of Molecularly-Informed Enrollment Into Early Phase Clinical Trials for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
‹
1
2
